Da Volterra logo — Clinical stage biotechnology company whose vision is to be a...

Da Volterra

Clinical stage biotechnology company whose vision is to be a trusted and acknowledged leader in the microbiome field.

Founded 2000 France France 7 employees Biotechnology

General Information

Company Name Da Volterra
Founded Year 2000
Location France France +1
Employees 7
Industries Biotechnology
Social

Get notified when Da Volterra moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Da Volterra

Da Volterra is a clinical stage biotechnology company with a vision to become a trusted and acknowledged leader in the microbiota field. The company's mission is to discover, develop, and bring to market safe and novel therapeutic options that preserve patients’ microbiota to prevent and cure life-threatening diseases. Da Volterra aims to transform the promise of science into innovative treatments that can improve health and save lives. Committed to innovation, the company develops products intended to protect the intestinal microbiota or harness its potential to help prevent and cure human diseases. Since its inception in 2000, Da Volterra has gathered unique in-house expertise on the intestinal microbiota and its links to different body functions, antibacterial drugs, and other drugs disrupting the microbiota, as well as drug delivery technologies. As a biotechnology company, Da Volterra is at the forefront of developing therapies that could have a transformative impact on healthcare. Although specific details about the headquarter location and the last investment round are not available, the company's focus on preserving and utilizing the microbiota for therapeutic purposes positions it at the intersection of cutting-edge biotechnology and healthcare innovation.

Taxonomy: microbiome research, clinical stage drug development, microbiota, therapeutic options, drug delivery technologies, antibacterial drugs, microbiota preservation, life-threatening diseases, microbiota disruption, intestinal microbiota, health innovation

No funding data available for Da Volterra yet.

Get notified when Da Volterra raises funding

Da Volterra Alternatives & Competitors

Da Volterra vs
Palisade Bio
Palisade Bio United States

Late-stage biopharma company advancing therapies for acute and chronic gastrointestinal (GI) complic...

Post Ipo Debt
15 employees
Biopharma, Biotechnology
Da Volterra vs
Every Cure
Every Cure United States

Every Cure is leveraging AI to unlock the full potential of every drug to treat every disease it pos...

Grant
38 employees
Biotechnology
Da Volterra vs

Transforming molecules to medicines

1 employees
Biotechnology, Health Care

FAQ About Da Volterra

Clinical stage biotechnology company whose vision is to be a trusted and acknowledged leader in the microbiome field.
Da Volterra was founded in 2000.
Da Volterra is headquartered in France.
Da Volterra operates in the following industries: Biotechnology.
Da Volterra has approximately 7 employees.
Top alternatives and competitors to Da Volterra include Palisade Bio, Every Cure, INVENT Pharmaceuticals, Microviable Therapeutics SL, Rani Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Da Volterra and Palisade Bio are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Da Volterra and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy